LIMITED STOCK AVAILABLEPRICES SHOWN WHERE AVAILABLE
GHRP-2 ACETATE

PERFORMANCE / SINGLE

GHRP-2 ACETATE

5MG · 10MG · 15MG
Important medical and research notice

This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.

Research Overview

A synthetic hexapeptide ghrelin-receptor agonist, studied in growth-hormone secretagogue research.

Available Strengths

  • 5MG (G25)
  • 10MG (G210)
  • 15MG (G215)

Research Protocol

Reference gradual titration

PeriodDoseU-100 unitsVolume
Weeks 1–20.1 mg60.06 mL
Weeks 3–40.15 mg90.09 mL
Weeks 5–160.2 mg120.12 mL

Reconstitution

Water volume3 mLConcentration1.667 mg/mLAdministrationSubcutaneousFrequencyOnce daily, typically eveningCycle length8–12 weeks in the reference protocol, optionally extended to 16 weeks.

≈1.67 mg/mL once reconstituted

  1. Draw 3.0 mL of bacteriostatic water per 5 mg vial.
  2. Inject slowly along the vial wall; swirl gently until dissolved.

Research context

Reported to potently stimulate pulsatile growth-hormone release by activating ghrelin receptors in the pituitary and hypothalamus, which may elevate IGF-1 levels over sustained use.

Storage

−20°C, stable 1+ years. 2–8°C, use within ~4 weeks; avoid freeze–thaw cycles.

Research Notes

  • For educational and research reference only. Not medical advice and not intended for unsupervised human use.

References

Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source